Xeltis is one of the 15 most promising private medtech companies included in this year’s global Fierce 15 list. The list is compiled evaluating hundreds of private companies from around the world on a variety of factors such as strength of technology, partnerships, venture backers and competitive market position. The Fierce 15 list is issued annually by FierceMedicalDevices, an internationally recognized authoritative daily report in medical technology.
